Research & Development
7 February 2025 - Chinese biopharmaceutical company Bio-Thera Solutions Inc (SHA:688177) said on Friday that the European Medicines Agency (EMA) has accepted the Marketing Authorisation Application (M...
7 February 2025 - Swedish research-based biopharma company BioArctic AB (STO:BIOA-B) announced on Friday that its partner Eisai Co Ltd (TYO:4523) has reported Leqembi (lecanemab) sales of JPY13.3bn fo...
6 February 2025 - Chinese biopharmaceutical company Shanghai Henlius Biotech Inc (HK:2696) announced on Wednesday that its anti-PD-1 mAb, HANSIZHUANG (serplulimab, marketed as Hetronifly in Europe), h...
5 February 2025 - Biotechnology company Adicet Bio Inc (Nasdaq: ACET) announced on Wednesday that it has received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for ADI-001, a...
5 February 2025 - Clinical stage precision medicine company Acrivon Therapeutics Inc (Nasdaq:ACRV) announced on Wednesday that the US Food and Drug Administration (FDA) has granted Breakthrough Device...
5 February 2025 - Contract Research Organisation hVIVO plc (AIM: HVO), a company that specialises in human challenge clinical trials, on Wednesday announced positive results from a Phase 2a trial cond...